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INTRODUCTION 
The man of 21st century is breathing under various 
adversities, stresses, strains and anxiety. The ever-
changing modes of livelihood force one to 
continuously   update   oneself   in   every   respect  to  
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survive and to keep at the pace with new 
developments. The lifestyle is far from what the 
natural anatomy and physiology of human body 
permits. Irregular and unnatural food habits, 
suppression of natural urges, lack of proper sleep and 
less time for relaxation are the inseparable parts of 
our routine which enervate body and finally lead to 
the disease. These physical factors, along with ever-
riding stressful psychological conditions contribute to 
most of the psychosomatic diseases. 
Ayurveda emphasizes on maintenance of positive 
health and alleviation of the diseases engulfing 
humankind, among which skin diseases are one, 
which are visible and agonizing the individual psycho-
somatically. Skin is the envelope of our body 
expressing the harmony inside. It is one of the five 
'Gyanendriyas' as told by Ayurveda, which is 
responsible for the perception of touch. It also 
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management of the Shvitra (Vitiligo). Materials and Method: In this study total 92 patients of 
Shvitra were registered at Panchakarma dept. of I.P.G.T. & R.A. Hospital, Jamnagar. Patients were 
randomly divided in three groups by lottery random sampling method. In Group A - Vamana Karma 
and in Group B - Virechana Karma was given. After Shodhana in both Groups and in Group C Oral 
administration of Darvigomootra Ghanavati 6g/day with the Apamarghkshara Lepa for 8 weeks was 
given. Result: In VASI Score 2.16% and 4.61% relief was found in Group A and B respectively which 
was statistically highly significant. While in Group C 0.38% relief was found which were statistically 
insignificant. Conclusion: Any kind of Shodhana therapy either Vamana or Virechana play a key role 
in the management of Shvitra. For long far and sustainable effect of the therapy Shodhana should be 
performed priorly. 
Key words: Shvitra, Vitiligo, Vamana, Virechana 
Hemang Raghavani et.al. Clinico comparative study of Vamana and Virechana Karma in Shvitra. 
ISSN: 2456-3110                                                    ORIGINAL ARTICLE Jan-Feb 2017 
 
Journal of Ayurveda and Integrated Medical Sciences | Jan - Feb 2017 | Vol. 2 | Issue 1 49 
 
performs functions such as protection of the body 
against physical, chemical, mechanical and biological 
injuries, thermoregulation etc. Besides all this it plays 
an important role in the expression of beauty, leaving 
impression. 
The skin has long been recognized as the ‘organ of 
expression’ and serves as the boundary between 
ourselves and the outside world. Dermatological 
disorders have an immediate impact on tactile 
communication and bodily interaction. So one of the 
baffling problems of mankind since time immemorial 
is the skin disease, which manifest in variety of forms. 
Shvitra is mentioned along with other types of 
Kushtha, but the difference between Shvitra and 
Kushtha is based on non-secretary and non-infectious 
nature of disease, involvement of Twaka only, 
peculiarity of Nidana, Asadhya Lakshana and 
chronicity. According to modern dermatology, Shvitra 
can be correlated with Vitiligo and Leucoderma. There 
are several diseases marked by a lack of pigment in 
the skin that are grossly referred to as Leucoderma; 
some are caused by an inability of melanocytes to 
produce melanin, while others are caused by 
melanocytes either not being present or being 
destroyed. Vitiligo is a progressive disease in which 
the melanocytes are gradually destroyed causing 
unpigmented areas on the skin. 
Many times common causes are observed as severe 
emotional stresses, (in some countries) social and 
emotional discrimination etc. Vitiligo may be become; 
a psychologically devastating disorder when it 
typically occurs in exposed areas (face and hands). 
According to the modern line of treatment PUVA 
(Psoralen + Ultra violet A) remains the therapy of 
choice along with the corticosteroid therapy, vitamin 
B12, folic acid, pseudocatalase, antioxidant, MSH 
analogues, khellin, calcium etc. PUVA has several 
adverse effects, so It is also time consuming and 
carries certain health risk for both patient and 
physician. Therefore it’s a time need look for harmless 
and as well as effective treatment in the Ayurveda. 
Acharya Charaka has mentioned that Samshamana 
therapy can be administered to patient after 
Shodhana therapy in this disease.
[1] 
Because of the 
chronic and relapsing nature of the disease radical 
therapies like Shodhana should be undertaken for 
long lasting relief. Sodhana essentially refers to bio-
purification of the body aiming to cleanse the macro 
and micro channels of the biological system-Srotas. 
Therefore, on the basis of classical references in the 
present study Vamana Karma and Virechana Karma,
[2]
 
Darvigomootra Ghanavati 
[3]
 and Apamarga Kshara 
Lepa
[4]
 has been selected in the treatment of Shvitra 
(Vitiligo). 
OBJECTIVES 
To evaluate and compare the efficacy of the Vamana 
and Virechana Karma in the management of the 
Shvitra (Vitiligo) and also to evaluate the clinical 
efficacy of Darvigomootra Ghanavati and Apamarga 
Kshara Lepa  in the management of the Shvitra 
(Vitiligo). 
MATERIALS AND METHODS 
Patients having sign and symptoms of Shvitra (Vitiligo) 
were selected for present studies. Patients fulfilling 
the criteria and attending OPD and IPD of Dept. of 
Panchakarma, and cases referred by other 
Departments of I.P.G.T. & R.A. Hospital, G.A.U. 
Jamnagar, were selected randomly irrespective of 
race, cast, sex, religion etc.  
The study was carried out after obtaining permission 
from institutional ethics committee. Inform concert 
(IC) of patients was taken prior to clinical study. After 
ethical clearance of the synopsis, study was registered 
in CTRI with registration no CTRI/2014/09/005004. 
Inclusion Criteria 
 Patients having sign and symptoms of Shvitra 
(Vitiligo) 
 Patients between age group of 15 years to 50 
years were selected. 
 Patients having chronicity less than 10 yrs.  
Exclusion Criteria 
 Patients complicated with any cardiovascular 
diseases, renal diseases, hepatic disease, 
carcinoma, major illness like IDDM, NIDDM, 
Hemang Raghavani et.al. Clinico comparative study of Vamana and Virechana Karma in Shvitra. 
ISSN: 2456-3110                                                    ORIGINAL ARTICLE Jan-Feb 2017 
 
Journal of Ayurveda and Integrated Medical Sciences | Jan - Feb 2017 | Vol. 2 | Issue 1 50 
 
patches due to burning, chemical explosion, any 
other serious systematic illness or any other 
disease effecting multiple body systems and 
pregnant women etc. 
 Patients contraindicated for Vamana and 
Virechana Karma as per classics.  
Study Design 
Randomised clinical trial, Interventional. Patients 
were allocated by using lottery randomisation 
method. 
Grouping  
In the present study 3 groups were done. 
 Group A - In this group classical Vamana Karma 
was given. Followed by oral administration of 
Darvigomootra Ghaanavati 6g/day with the 
Apamargakshara Lepa for duration of 8 weeks. 
 Group B - In this group classical Virechana Karma 
was given. Followed by oral administration of 
Darvigomootra Ghanavati 6g/day with the 
Apamargakshara Lepa for duration of 8 weeks. 
 Group C - Oral administration of Darvigomootra 
Ghanavati 6g/day with the Apamargakshara Lepa 
for duration of 8 weeks. 
Darvigomootra Ghanavati 
Prepared with Darvi (Berberis Aristata) and Gomootra 
(Cow Urine) by the classical method of Ghana Kriya. 
Apamargkshara Lepa 
Prepared with Apamarga Kshara and Gomootra. 
Advice 
All subjects were explained the Pathyapathya of 
Shvitra (Vitiligo). Nature of the diseases was explained 
and reassurance was given to all the subjects 
belonging to groups. 
Assessment 
There is acurrent lack of consensus on methods of 
assessment of this disorder, which makes it generally 
impossible to perform meta-analyses or compare the 
outcomes of different studies of the same treatment 
or parameter. Recently, the Vitiligo Area Scoring Index 
(VASI) tools was proposed to offer more accurate 
measures of disease severity indexes and treatment 
evaluation criteria compared to simple clinical 
photography alone. VASI provides a relatively simple 
method, analogous to the Psoriasis Area Severity 
Index (PASI), to measure repigmentation. With the 
VASI score difference of color of the patch was 
analysis. On the basis of VASI score and color of the 
patch overall assessment was analyzed.  
Criteria for the assessment of overall effect of the 
therapies 
For this purpose, following categories were 
maintained. 
 Worsened: Disease condition worsen with the 
increases in VASI Score. 
 Unchanged: No changes in VASI score and color of 
the patches. 
 Mild improvement: Below 25% improvement in 
VASI score and color of the patches. 
 Moderate improvement: 26%-50 % improvement 
in VASI score and color of the patches. 
 Marked improvement: 51%- 75% improvement in 
VASI score and color of the patches. 
 Complete remission: 76%-100% improvement in 
VASI score and color of the patches. 
OBSERVATION 
Total 92 patients were registered in present clinical 
study i.e.30 in Group A (Vamana Karma + Shamana 
Karma) and 31 in Group B (Virechana Karma + 
Shamana Karma) and Group C (Shamana Karma) 
respectively. 28 patients in Group A, 30 patients in 
Group B while 29 patients in Group C had completed 
the treatment. 2 patients left against the medical 
advice in Group A and Group C each and 1 patient left 
against the medical advice in Group B.  
Among demographic data, it was found that, 
Maximum patients i.e. 46.67% were from the group of 
16 – 30 years, 57.61% were females, 26.09% were 
having chronicity of 2 years, 23.91% were having 
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positive family history.  43.48% of the patients were 
of Vatapittajprakriti, 38.04% patients were having 
Vishama Agni, 59.78% patients were having 
Madhyama Kostha, 66.30% had Katu Rasa dominancy 
in their diet, 45.65% had Guru Guna dominant diet, 
56.82% patients were with Rasavahasroto Dusti, while 
54.34% patients had Raktavaha Srotodusti. 19.57% of 
the patients were observed in taking Milk+Amla and 
14.13% observed with Milk+Lavana with type of 
Viruddhahara as a Nidana.  
In Group A (Vamana) average number of Vega was 5, 
average number of Upavega was 10. Pittantashuddhi 
was found in 53.33% of patients, 66.67% of the 
patients MadhyamaShuddhi was achieved. 
In Group B Average 16 no. of Vega obtained in 31 
patients of Virechana group. Kaphanta Lakshana was 
observed in 96.77% of the patients. 90.32% of the 
patients Madhyama Shuddhi was achieved. 
75% of the patients had white coloured patches of 
skin observed and 13.04% of the patients had red to 
whitish coloured patches of skin observed. 
44.57% of the patients had more than 4 patches, 
18.48% had  2 and 3 patches respectively, 66.30% of 
the patients had involved 1 percentage areas of the 
body while 15.22% had more than 4 percentage areas 
involved, 53.26% of the patients had more than 4cm 
size of patches. 
Figure 1: Demographic data of 92 patients of Shvitra. 
 
RESULTS 
In Group A the initial mean score of VASI of patches 
was 2.35 which got reduced up to 2.30 and relief was 
by 2.16% which was statistically highly significant 
(p<0.0001). In Group B the initial mean score was 1.02 
which has been reduced to 0.97 by 4.61% relief and 
the result was statistically highly significant 
(p<0.0001). In Group C the initial mean score was 
0.866 which has been reduced to 0.863 by 0.38% 
relief and the result was statistically insignificant 
(p<0.0001). 
In Group A the initial mean score of color of patches 
was 4.32 which got reduced up to 3.71 and relief was 
by 14.32% which was statistically highly significant 
(p<0.001). In Group B the initial mean score was 4.87 
which has been reduced to 4.13 by 15.07% relief and 
the result was statistically highly significant (p<0.001). 
While in Group C the initial mean score was 4.55 
which has been reduced to 4.07 by 10.60% relief and 
the result was statistically highly significant (p<0.001). 
Table 1: Comparative effect of therapies. 
Parameter Anova 
(Kruskal-
Wallis 
Statistic) 
P Comparison 
between 
groups 
(Dunn’s 
Test) 
Mean 
diff. 
of 
ranks 
P 
VASI 13.96 <0.05 A-B -5.83 >0.05 
A-C 16.75 * 
B-C 22.57 *** 
Colour 1.31 >0.05 A-B 1.44 >0.05 
A-C 6.44 >0.05 
B-C 4.99 >0.05 
*=  significant, **= highly significant, ***= highly highly 
significant 
DISCUSSION 
According to modern science it may appear at any age 
cases have been reported as early as 6 weeks after 
birth and after 80 years of age.
[5]
 Ayurvedic texts have 
told Shvitra as Pittapradhana Tridoshaja Vyadhi. This 
is evident from above data as Shvitra is more 
prevalent in age group which was Pitta Pradhana.
[6]
 
According to modern science male and female both 
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are equally affected from this disease.
[7]
 So the 
observed findings are due to smaller sample size or 
female ratio is more than male may be due to female 
is more conscious than male about cosmetic values. 
Percentage improvement in color of patches of both 
(Vamana and Virechana) Shodhana therapy show 
better improvement than Shamana therapy. In the 
classical texts they mentioned that through Virechana 
one can get Varna Shuddhi,
[8]
 so here Virechana 
Group shows better result in colour of the patches 
than other groups. However in comparison there 
is no statistically significant (p>0.05) difference was 
found between three therapies in the improvement of 
colour of patches. 
On effect of VAS Score comparison between the 
groups, statistically highly significant difference was 
seen between groups B and C and in groups A and C 
statistically significant difference was found. However 
between group A and B no significant (p>0.05) 
difference was noted. It means Group A and Group 
B which is Shodhana therapy shows the better result 
in VASI score than Shamana. However in the 
comparison of Shodhana therapy no significant 
difference was found which means any kind of 
Shodhana either Vamana or Virechan plays a key role 
in the management of Shvitra. (Table 1) 
VASI score is used for main assessment of 
pigmentation on the skin. In classical texts skin is 
mentioned as one of the Indriya. During the 
description of the benefits of both Vamana and 
Virechana Karma our Acharyas mentioned that both 
Karma make Indriya Shuddhi,
[9],[10]
 that’s why both 
Shodhana therapies show better result than Shamana 
therapy. In comparison between Vamana and 
Virechana groups; Virechana group shows better 
result, it may be due to significant changes were 
found in Raktavahasrotodusti through Virechana
[11] 
and Rakta is mentioned as one of main Dushya of 
Shvitra.
[12]
 
Overall effect of therapy  
In Group A: 7.14% patients showed moderate 
improvement and 78.57% showed mild improvement. 
10.71% patients reported with unchange, while in 
3.57% of the patient observed with worsened 
condition of the diseases. None of patient showed 
complete remission or marked improvement. 
In Group B:   3.33% patients showed marked 
improvement, 10% patients showed moderate 
improvementand 66.67% showed mild improvement. 
20% patients reported with unchanged condition. 
None of patient showed complete remission or 
worsened. 
In Group C: 3.45% patients showed moderate 
improvement and 37.93% showed mild improvement. 
44.83% patients reported with unchanged, while in 
13.79% of the patient observed with worsened 
condition of the diseases. None of patient showed 
complete remission or Marked Improvement. 
It means though no significant difference was found 
between Vamana and Virechana therapy. With 
Virechan Karma one can manage the disease with the 
good possibilities of getting better result because in 
Harita Samhita it is mentioned that the vitiation of 
Vata along with the Pitta Dosha spoil the Rakta Dhatu 
and create the spot of Pandura Varna that is called 
Shvitra and has mentioned Pandura as Shvitra. In this 
way the specific line of treatment Virechana is alone 
mentioned by Aacharya Harita.
[13]
 According to 
Acharya Charaka, Svitra has been considered under 
one of the Rakta Pradoshaja Vikara. So following line 
of treatment can be taken for consideration.
[14] 
In 
diseases having blood as causative factor line of 
treatment is one pacifying Rakta and Pitta. Also, 
Virechana, Upavasa and Raktamokshana can be 
given.
[15]
 Acharya Charaka has mentioned that 
Shamana therapy can be administered to patient after 
Sodhana therapy. Acharya has praised Virechana 
Karma as the best modalitiy for Pitta Dosha. Rakta 
and Pitta are considered as Ashrayiashrita and hence 
Virechana suits best for Pitta. 
CONCLUSION 
The result of both  Shodhana therapies were 
statistically highly significant, though no significant 
difference was found between Vamana and Virechana 
therapy. Virechana group provided marked 
improvement and it is easy to perform with less 
complication and it emphasizes the importance of 
Shodhana in Shvitra. Result in color of patches 
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indicates that for longer and sustainable effect of the 
therapy Shodhana should be performed priorly. 
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